These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29239194)

  • 1. [Immunotherapy of Renal Cell Carcinoma].
    Poprach A; Lakomý R; Büchler T
    Klin Onkol; 2017; 30(Supplementum3):55-61. PubMed ID: 29239194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy in the Treatment of Lung Cancer].
    Fiala O; Šorejs O; Pešek M; Fínek J
    Klin Onkol; 2017; 30(Supplementum3):22-31. PubMed ID: 29239189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy for Bladder Cancer].
    Büchler T
    Klin Onkol; 2017; 30(Supplementum3):6-9. PubMed ID: 29239187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Checkpoint Inhibitors in the Treatment of Upper Gastrointestinal Tract Tumors].
    Obermannova R
    Klin Onkol; 2017; 30(Supplementum3):50-54. PubMed ID: 29239193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
    Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on immunotherapy for renal cancer.
    Canales Rojas R
    Medwave; 2021 Jun; 21(5):e8202. PubMed ID: 34214067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in Immunotherapy of Malignant Melanoma].
    Krajsová I
    Klin Onkol; 2017; 30(Supplementum3):40-44. PubMed ID: 29239191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice.
    Massari F; Nunno VD; Mollica V; Montironi R; Cheng L; Cimadamore A; Blanca A; Lopez-Beltran A
    Immunotherapy; 2019 Dec; 11(17):1507-1521. PubMed ID: 31663411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy of Colorectal and Anal Carcinoma].
    Tomášek J; Kiss I
    Klin Onkol; 2017; 30(Supplementum3):62-65. PubMed ID: 29239195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in genitourinary malignancies.
    Mehta K; Patel K; Parikh RA
    J Hematol Oncol; 2017 Apr; 10(1):95. PubMed ID: 28434403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint inhibitor immunotherapy in kidney cancer.
    Xu W; Atkins MB; McDermott DF
    Nat Rev Urol; 2020 Mar; 17(3):137-150. PubMed ID: 32020040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side Effects and Efficacy of Immunotherapy.
    Fiala O; Šorejs O; Šustr J; Fínek J
    Klin Onkol; 2020; 33(1):8-10. PubMed ID: 32075381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitors for nonsmall cell lung cancer treatment.
    Chen YM
    J Chin Med Assoc; 2017 Jan; 80(1):7-14. PubMed ID: 27693088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decade of immune-checkpoint inhibitors in cancer therapy.
    Robert C
    Nat Commun; 2020 Jul; 11(1):3801. PubMed ID: 32732879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
    Dhariwal R; Pindoria N; Dasgupta P; Khan MS
    BJU Int; 2019 Feb; 123(2):203-207. PubMed ID: 29974606
    [No Abstract]   [Full Text] [Related]  

  • 17. From Clinical Trials to Real-life Clinical Practice: The Role of Immunotherapy with PD-1/PD-L1 Inhibitors in Advanced Urothelial Carcinoma.
    Hussain SA; Birtle A; Crabb S; Huddart R; Small D; Summerhayes M; Jones R; Protheroe A
    Eur Urol Oncol; 2018 Dec; 1(6):486-500. PubMed ID: 31158093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy for renal cell carcinoma - current status].
    Grimm MO; Foller S
    Aktuelle Urol; 2018 Apr; 49(2):187-191. PubMed ID: 29587324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical decision-making for immunotherapy in metastatic renal cell carcinoma.
    Schmidinger M
    Curr Opin Urol; 2018 Jan; 28(1):29-34. PubMed ID: 29045250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Immune Therapies Targeting Ovarian Cancer.
    Fan CA; Reader J; Roque DM
    Curr Treat Options Oncol; 2018 Nov; 19(12):74. PubMed ID: 30430276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.